Voriconazole: Difference between revisions
From IDWiki
(→) |
No edit summary |
||
| Line 1: | Line 1: | ||
== Dosing == |
|||
== Dose Adjustment Guidelines == |
|||
{| class="wikitable" |
{| class="wikitable" |
||
| Line 23: | Line 23: | ||
| Hold dose. Follow daily trough levels, then restart when trough is ≤2.5 at a dose decreased by 50%. Recheck trough level on day 5 of new regimen. |
| Hold dose. Follow daily trough levels, then restart when trough is ≤2.5 at a dose decreased by 50%. Recheck trough level on day 5 of new regimen. |
||
|} |
|} |
||
== Adverse Effects == |
|||
* Visual |
|||
** Floaters etc that may improve with time |
|||
** Visual hallucinations |
|||
* Hepatotoxicity |
|||
* QTc prolongation |
|||
== Further Reading == |
== Further Reading == |
||
Revision as of 20:57, 10 September 2019
Dosing
| Trough (mcg/mL) | Recommendation |
|---|---|
| 0.0 to 0.6 | Increase dose by 100 mg and recheck trough on day 5 of new regimen |
| 0.7 to 0.9 | Increase dose by 50 mg and recheck trough on day 5 of new regimen |
| 1.0 to 4.0 | At target, no dose adjustment needed |
| 4.1 to 5.5 | Decrease dose by 50 mg and recheck trough on day 5 of new regimen |
| 5.6 to 7.9 | Hold dose. Follow daily trough levels, then restart when trough is ≤2.5 at a dose decreased by 100 mg. Recheck trough on day 5 of new regimen. |
| ≥8.0 | Hold dose. Follow daily trough levels, then restart when trough is ≤2.5 at a dose decreased by 50%. Recheck trough level on day 5 of new regimen. |
Adverse Effects
- Visual
- Floaters etc that may improve with time
- Visual hallucinations
- Hepatotoxicity
- QTc prolongation
Further Reading
- Voriconazole Dose Modification Guideline to Optimize Therapeutic Levels in Patients With Hematologic Malignancies. Open Forum Infect Dis. 2015(2)S1:810.
